TABLE 1:

Summary of patient characteristics and treatment

Case No.	Sex	Age	Lesion Location	Comorbidities	Mori Lesion Type	Stenosis (%)		Predilatation (mm)	Stent (mm)	Complication
Case No.	Sex	Age	Lesion Location	Comorbidities	Mori Lesion Type	Before	After	Predilatation (mm)	Stent (mm)	Complication
1	F	58	BA	H	B	59	0	Maxxum 2.75/12	S660 2.75/18	Acute in-stent thrombosis^*
2	F	63	BA	H, D, L	A	65	5		Jo flex 4/16
			IVA, Lt		C	60	0		S670 3/24
3	F	65	IVA, Lt	H	B	62	10		S670 3.5/18
4	M	60	BA	H	C	82	0	Maverick 2/12	Cypher 2.5/13	Dizziness, ataxia^†
5	M	51	IVA, Rt	H, D, S	C	95	0	Maestro 1.5/20	Jo flex 2.5/23
6	M	70	IVA, Lt	H, D, S, C	A	90	0		S670 4/18
7	F	66	IVA, Lt	H, D	B	70	0		Jo flex 4/23
8	M	55	IVA, Lt	H, D, L, S, C	A	95	0		S660 2.5/9, 2.5/12^‡
9	M	70	IVA, Rt	H, C	C	70	0		Jo bare 5/17
10	M	74	IVA, Rt	H, D, S, M	B	69	0	Ranger 2.5/20	AVE 3.5/12
11	F	60	BA	H	C	95	0		S670 3/18
12	M	69	BA	H	B	90	0		Jo flex 3.5/16
13	M	62	IVA, Lt	H, L	B	74	0	Larus 2.5/10	Jo Stent 3.0/12
14	F	65	BA	H	C	90	5		S670 3.5/24
			IVA, Lt		B	60	0		S670 4/24
15	F	76	IVA, Lt	H, D, L, S	C	80	0		S660 2.5/15,S670 3/19^§
16	M	68	IVA, Lt	H, S, C	C	50	5		S7 4/30
17	M	60	IVA, Lt	H, L, S	C	90	0	Maestro 1.5/20	Jo flex 3/19

Note.—IVA indicates intracranial vertebral artery; BA, basilar artery; H, hypertension; D, diabetes mellitus; L, hyperlipidemia; S, smoking; C, coronary artery disease.
* Recanalized after intraarterial abciximab injection.
† Improved during hospitalization.
‡ First stent was trapped by the tight stenosis and had to be deployed proximal to the lesion site; thus, a second stent was used for distal angioplasty.
§ Two stents used for long length of the lesion.